Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK Adams Respiratory Therapeutics is launching its new product Mucinex next month and has awarded the consumer advertising to Interpublic Group’s Torre Lazur McCann Healthcare, the client said.
The Chester, N.J., client markets and sells respiratory disease medications. Torre Lazur joined the roster in 2003, handling the company’s professional and managed-care business. Ad spending was not disclosed.
In a statement, client president and CEO Michael Valentino said, “The agency’s strategic and creative recommendations have demonstrated an astute knowledge of our products and customers.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in